4//SEC Filing
Wegman Mark N 4
Accession 0001062993-18-003711
CIK 0000875622other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 9:23 PM ET
Size
6.7 KB
Accession
0001062993-18-003711
Insider Transaction Report
Form 4
Wegman Mark N
Director
Transactions
- Sale
Common Stock, $0.001 par value
2018-09-11$58.66/sh−1,000$58,655→ 65,272 total - Sale
Common Stock, $0.001 par value
2018-09-10$57.31/sh−5,500$315,206→ 66,272 total
Footnotes (2)
- [F1]The selling price of $57.3102 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $56.22 to $58.902. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The selling price of $58.655 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $58.64 to $58.67. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001405235
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 9:23 PM ET
- Size
- 6.7 KB